TGM2 and myeloid sarcoma: However serological anti-tTG6-Ab levels could not reflect the amount of these antibodies and severity of immune responses as well as ataxia in the central nervous system.17 Some studies on the MS population in Iran and Italy reported negative anti-tTG antibody titer in all patients with MS.